Long-term Outcome after Multidisciplinary Approach for Leptomeningeal Carcinomatosis in a Non-small Cell Lung Cancer Patient with Poor Performance Status

Author:

Nagano Tatsuya1,Kotani Yoshikazu1,Kobayashi Kazuyuki1,Hatakeyama Yukihisa1,Hori Suya1,Kasai Daisuke1,Funada Yasuhiro1,Nishimura Hideki2,Kondoh Takeshi3,Nishimura Yoshihiro1

Affiliation:

1. Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan

2. Divison of Radiation Oncology, Department of Radiology, Kobe University Graduate School of Medicine, Japan

3. Department of Neurosurgery, Kobe University Graduate School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Reference13 articles.

1. Leptomeningeal carcinomatosis

2. 2. Kim DY, Lee KW, Yun T, et al. Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone. Jpn J Clin Oncol 33: 608-612, 2003.

3. Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

4. 5. Omuro AM, Kris MG, Miller VA, et al. High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib. Cancer 103: 2344-2348, 2005.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3